G01N 2800/2871
Cerebrovascular disorders
Official title: Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
G01N2800/2871 (Cerebrovascular disorders) appears on 179 US grants and 437 published applications in this corpus.
Search patents in G01N- Granted patents
- 179
- Published applications
- 437
- Assignees
- 258
- Inventors
- 798
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 6 |
| 2004 | 1 | 5 |
| 2005 | 1 | 11 |
| 2006 | 1 | 13 |
| 2007 | 1 | 11 |
| 2008 | 5 | 11 |
| 2009 | 5 | 12 |
| 2010 | 9 | 30 |
| 2011 | 9 | 17 |
| 2012 | 3 | 15 |
| 2013 | 12 | 24 |
| 2014 | 8 | 20 |
| 2015 | 3 | 26 |
| 2016 | 9 | 15 |
| 2017 | 13 | 16 |
| 2018 | 12 | 23 |
| 2019 | 13 | 24 |
| 2020 | 11 | 24 |
| 2021 | 11 | 26 |
| 2022 | 11 | 20 |
| 2023 | 6 | 32 |
| 2024 | 8 | 20 |
| 2025 | 13 | 15 |
| 2026 | 10 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods, systems, and a kit for diagnosis, detection, monitoring and treatment of traumatic brain injury15 Sep 2026US 12,736,546 B2RapidDx, Inc.
- Method for selecting a patient for a reperfusion therapy14 Jul 2026US 12,681,022 B2Fundació Hospital Universitari Vall D'Hebron—Institut De Recerca
- Magnetic point-of-care systems and assays for determining GFAP in biological samples30 Jun 2026US 12,669,513 B2Abbott Laboratories
- Binding molecule binding to traumatic brain injury-associated tau and methods of use thereof23 Jun 2026US 12,662,678 B2Arizona Board of Regents on behalf of Arizona State University
- Methods for treating cerebral vasospasm with a PD-1 agonist2 Jun 2026US 12,644,888 B2The Johns Hopkins University
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Magnetic point-of-care systems and assays for determining gfap in biological samples8 Oct 2026US 2026/0309722 A1Abbott Laboratories
- Method for selecting a patient for a reperfusion therapy1 Oct 2026US 2026/0298946 A1Fundació Hospital Universitari Vall D'Hebron—Institut De Recerca
- Methods for inhibiting macrophage neurotoxicity17 Sep 2026US 2026/0276627 A1Ajou University Industry-Academic Cooperation Foundation
- Compositions and methods for treating cerebral vasospasm10 Sep 2026US 2026/0266819 A1
Most cited
By later US patents
- IL1RL-1 as a cardiovascular disease marker and therapeutic target48US 7,670,769 B2The Brigham and Women S Hospital, Inc. · 2010
- Methods for diagnosis of cardiovascular disease47US 7,432,060 B2The Brigham and Women S Hospital, Inc. · 2008
- IL1RL-1 as a cardiovascular disease marker and therapeutic target42US 7,655,415 B2The Brigham and Women S Hospital, Inc. · 2010
- Methods for diagnosis of cardiovascular disease40US 7,985,558 B2The Brigham and Women S Hospital, Inc. · 2011
- IL1RL-1 as a cardiovascular disease marker and therapeutic target40US 7,989,210 B2The Brigham and Women S Hospital, Inc. · 2011